IMS Health (IMS) Tops Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
UBS Starts IMS Health Holdings (IMS) at Neutral (Earlier)
February 5, 2015 11:10 AM ESTUBS earlier initiated coverage on IMS Health Holdings (NYSE: IMS) with a Neutral rating and a price target of $27. Analyst Steven Valiquette said it was a solid company but in his view FX mutes growth near-term.
"IMS is a leader in healthcare data... More



